You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 297 Modeling the efficacy of NY-ESO-1 TCR T cells (letetresgene autoleucel; GSK3377794) in patients with synovial sarcoma: correlations of response with transduced cell kinetics and biomarkers

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Clinical trials completed
297 Modeling the efficacy of NY-ESO-1 TCR T cells (letetresgene autoleucel; GSK3377794) in patients with synovial sarcoma: correlations of response with transduced cell kinetics and biomarkers

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020220027
Dec 20202205
Jan 20212201
Feb 20213207
Mar 20214606
Apr 202156022
May 20213107
Jun 20210012
Jul 20210010
Aug 2021006
Sep 2021009
Oct 202128024
Nov 202122014
Dec 20212607
Jan 20223603
Feb 202224011
Mar 20223805
Apr 20226008
May 202244011
Jun 20223207
Jul 20223005
Aug 20224205
Sep 20223403
Oct 20222403
Nov 20222807
Dec 20222000
Jan 20233802
Feb 20232201
Mar 202336023
Apr 20231203
May 20232002
Jun 20231006
Jul 20231002
Aug 20231201
Sep 20231401
Oct 20231402
Nov 20232202
Dec 20235001
Jan 20241600
Feb 20244401
Mar 20241802
Apr 20242401
May 20241600
Jun 20242400
Jul 2024800
Aug 20241401
Sep 20242002
Oct 20241605
Nov 20241602
Dec 20241404
Jan 202512010
Feb 2025202
Mar 2025203
Apr 2025002
May 2025003
Jun 2025003
Total14230312